Showing results (201-210 of 330) with videos related to
Sort By:
Pageof 33
Frontiers in Psychiatry|October 11, 2017
Increased Subjective Distaste and Altered Insula Activity to Umami Tastant in Patients with Bulimia NervosaRikukage Setsu, Yoshiyuki Hirano, Miki Tokunaga, et al.Annals of General Psychiatry|February 19, 2021
Perception of and anxiety about COVID-19 infection and risk behaviors for spreading infection: an international comparisonAkihiro Shiina, Tomihisa Niitsu, Osamu Kobori, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 29, 2009
Impaired P50 suppression in fear extinction in obsessive-compulsive disorderMakoto Nanbu, Taichi Kurayama, Ken Nakazawa, et al.Current Neuropharmacology|September 3, 2011
Association analysis of the tryptophan hydroxylase 2 gene polymorphisms in patients with methamphetamine dependence/psychosisHideaki Kobayashi, Hiroshi Ujike, Nakao Iwata, et al.Neuroscience Letters|October 30, 2003
Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controlsEiji Shimizu, Kenji Hashimoto, Hiroyuki Watanabe, et al.Psychiatry Research|October 17, 2003
Increased levels of serum basic fibroblast growth factor in schizophreniaKenji Hashimoto, Eiji Shimizu, Naoya Komatsu, et al.Biological Psychiatry|July 5, 2003
Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressantsEiji Shimizu, Kenji Hashimoto, Naoe Okamura, et al.Schizophrenia Research|June 4, 2014
Second-generation antipsychotics and bone turnover in schizophreniaKyoji Okita, Nobuhisa Kanahara, Motoi Nishimura, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 31, 2004
Possible role of D-serine in the pathophysiology of Alzheimer's diseaseKenji Hashimoto, Takeshi Fukushima, Eiji Shimizu, et al.Schizophrenia Research|June 2, 2005
Tropisetron improves deficits in auditory P50 suppression in schizophreniaKaori Koike, Kenji Hashimoto, Nobuyuki Takai, et al.Pageof 33